A review of some recently published scientific studies includes one for antihistamines and similar compounds that might slow down Huntington’s disease.

Novartis received approval from the U.S. Food and Drug Administration for the Swiss pharmaceuticals company’s drug Beovu to treat a cause of vision loss.